Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
AHA comments regarding HHS' proposed rule on nondiscrimination in health programs and activities.
AHA comments regarding Department of Health and Human Services (HHS) proposed rule on
AHA letter to Representative Charles Dent endorsing HR 3537, the Synthetic Drug Control Act of 2015.
AHA strongly supports many of the provisions of the Health Benefit Plan Network Access and Adequacy Model Act (Model Act) as approved by the National Association of Insurance Commissioners' (NAIC) Regulatory Framework (B) Task Force.